WAKEFIELD, Mass.--(BUSINESS WIRE)--Implant Sciences Corporation (AMEX: IMX) a developer and manufacturer of products for national security, medicine and industry, today announced that CorNova GmbH, a wholly-owned German subsidiary of CorNova, Inc., has received CE Mark marketing approval for its ValecorTM Coronary Stent System. Implant Sciences is a major investor in CorNova Inc. with an eighteen percent (18%) ownership interest. This advanced cobalt-chromium stent uses an innovative design that was developed to maximize flexibility and conformity while providing uniform expansion and coverage. Utilizing some of the thinnest struts of any commercialized coronary stent, the Valecor stent minimizes strut thickness which is believed to play a significant role in reducing restenosis.
